Skip to main content

Advertisement

Table 2 Patients who filled the questionnaires: younger vs. older patients

From: Health related quality of life after oesophagectomy: elderly patients refer similar eating and swallowing difficulties than younger patients

  Age < 70 Age > =70 p-value
N 86 23 -
Gender Male: Female 73:13 19:4 0.75
Age (years)a 58 (51–64) 75 (72–80) <0.0001
Histotype:b    0.14
 Adenocarcinoma 62 (72.9) 13 (56.5)  
 Squamous cell carcinoma 23 (27.1) 10 (43.5)  
Tumour site:    0.42
 Cervical oesophagus 6 (7.0) 0  
 Thoracic oesophagus 10 (11.6) 4 (17.4)  
 Oesophago-gastric junction 70 (81.4) 19 (82.6)  
Prognostic nutritional indexa 49.0 (46.5–52.0) 48.2 (44.4–50.7) 0.39
Charlson Comorbidity Indexa 2 (2–3) 3 (2–3) 0.09
Age related Charlson Comorbidity Indexac 3 (2–4) 5 (5–6) <0.0001
Neoadjuvant therapy 75 (87.2) 15 (65.2) 0.03
Type of neoadjuvant therapy:    -
 Chemotherapy 24 (32.0) 5 (33.3)  
 Radiotherapy 1 (1.3) 0  
 Chemo-radiotherapy 50 (66.7) 10 (66.7)  
Hospital stay (days)a 19 (16–24) 23 (18–30) 0.04
Pathological staged    0.07
 0 23 (26.7) 2 (8.7)  
 I 16 (18.6) 4 (13.0)  
 II 14 (16.3) 10 (43.5)  
 III 29 (33.7) 7 (30.4)  
 IV 4 (4.7) 1 (4.4)  
Post-operative morbidity 20 (23.3) 9 (39.1) 0.18
  1. Data expressed as n (%) or amedian (IQR)
  2. bOther histotype in one patient
  3. cComparison biased due to age penalization in score calculation
  4. dPathological stage is ypstage for patients who received neoadjuvant therapy and pstage for patients who did not